A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Clinical trial NCT05844228 · COMPLETED
Trial details
- NCT number
- NCT05844228
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.